November 2014 Awareness Night – 20th Anniversary Celebration Watch this video of our 20th anniversary celebration: A bit of history from our founding as Man to Man to our joining the Prostate Cancer Canada Network Congratulatory messages from the medical community Our position on PSA testing as presented by PCC’s President and CEO Rocco Rossi CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 54:38 minutes
20th Anniversary Video Read More »
A new study published in the Journal of Clinical Oncology has found that men who have higher-than-normal prostate-specific antigen (PSA) levels in middle age are more likely to have fatal prostate cancer later in life. Read the article here.
High PSA levels in middle-age men could indicate higher risk for prostate cancer Read More »
Prostate specific antigen, or PSA, tests correctly predicted whether a man would have lethal prostate cancer later in life more than three-quarters of the time, researchers at Harvard University report in a new study. Read the article here.
PSA test best at predicting lethal prostate cancer, study says Read More »
Recommendations against routine PSA screening from the US Preventive Services Task Force (USPSTF) are based largely on a landmark trial showing that such screening does not decrease the risk of death from prostate cancer (PCa), but this conclusion may be invalid. Read the article.
Landmark PSA Screening Trial Results Challenged Read More »
May 2016 Awareness Night A twenty year personal reflection on the privilege of caring for men with prostate cancer Dr. Rajiv Singal, MD, FRCSC Endourology, Urologic Cancer and Robotic Surgery Michael Garron Hospital Asst. Prof., Dept. of Surgery, U. of Toronto CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 39:36 minutes
A 2013 study published in the International Journal of Cancer raises concerns about alcohol’s ability to throw off prostate cancer tests. The investigators found a modestly higher risk of prostate cancer among heavy drinkers; they also observed evidence of lower PSA levels associated with increasing consumption of alcohol. This means it can be more difficult to detect prostate cancer using PSA levels among men who are heavy drinkers. In an older study of Harvard alumni, researchers concluded wine or beer consumption was unassociated with prostate cancer; however, moderate liquor consumption was associated with a significant 61-67 percent increased risk of
Alcohol, especially liquor, increases prostate risk and skews PSA Read More »
A new study published in The Journal of Urology® revealed that African American men with Gleason score 3+3=6 prostate cancer (PCa) produce less prostate specific antigen (PSA) and have significantly lower PSA density (PSAD) than Caucasian men. These findings could have important implications when selecting patients for inclusion in active PCa surveillance programs. Read the article.
In partnership with Cancer Council Australia and a multi-disciplinary expert advisory panel comprising urologists, medical oncologists, radiation oncologists, pathologists, general practitioners, epidemiologists, allied health professionals and consumers, Prostate Cancer Foundation of Australia has developed national evidence-based clinical practice guidelines on PSA testing and early management of test-detected prostate cancer. Read the article.
Australia PSA Testing Guideline Recommendations Read More »
Prostate-specific antigen (PSA)-based screening for prostate cancer has long been controversial. With guidelines changing on a regular basis and experts disagreeing over its use, determining whether or not to get tested can be confusing. Arming yourself with a better understanding of the issues can guide your decision-making process. Read the article.
What Every Man Should Know About Prostate Cancer Screening Read More »
PSA production may be lower in African-American than Caucasian men with low-risk prostate cancer (PCa), a new study suggests. If confirmed, the finding could impact active surveillance criteria for black patients. Read the article.
Black Men with Low-Risk Prostate Cancer Produce Less PSA Read More »